BE901411A - Compose antiobiotique, procede pour le preparer et compositions le contenant. - Google Patents

Compose antiobiotique, procede pour le preparer et compositions le contenant.

Info

Publication number
BE901411A
BE901411A BE0/214265A BE214265A BE901411A BE 901411 A BE901411 A BE 901411A BE 0/214265 A BE0/214265 A BE 0/214265A BE 214265 A BE214265 A BE 214265A BE 901411 A BE901411 A BE 901411A
Authority
BE
Belgium
Prior art keywords
same
preparing
compound
antiobiotic
compositions containing
Prior art date
Application number
BE0/214265A
Other languages
English (en)
Inventor
M L A Marvola
E V Marttila
J A Uotila
A K Pippuri
P J Jairisalo
E J Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of BE901411A publication Critical patent/BE901411A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)

Abstract

Nouveau composé antibiotique, le stéarate d'acétyl érythromycine représenté par la formule I: Il est préparé en faisant réagir l'érythromycine-base avec un halogémure d'acétyle en présence d'un accepteur d'acide et ou prépare ensuite le stéarate à partir de l'ester obtenu, sans l'isoler au préalable. Composition antibiotique avec bonne absorbtion.
BE0/214265A 1984-01-06 1984-12-28 Compose antiobiotique, procede pour le preparer et compositions le contenant. BE901411A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
BE901411A true BE901411A (fr) 1985-04-16

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214265A BE901411A (fr) 1984-01-06 1984-12-28 Compose antiobiotique, procede pour le preparer et compositions le contenant.

Country Status (38)

Country Link
US (1) US4599326A (fr)
JP (1) JPS60158197A (fr)
KR (1) KR900006237B1 (fr)
AT (1) AT386414B (fr)
AU (1) AU565688B2 (fr)
BE (1) BE901411A (fr)
BG (1) BG43189A3 (fr)
CA (1) CA1224461A (fr)
CH (1) CH666275A5 (fr)
CS (1) CS247191B2 (fr)
CY (1) CY1462A (fr)
DE (1) DE3500179A1 (fr)
DK (1) DK149776C (fr)
ES (1) ES8605818A1 (fr)
FI (1) FI77249C (fr)
FR (1) FR2557878B1 (fr)
GB (1) GB2152502B (fr)
HK (1) HK11590A (fr)
HU (1) HU196221B (fr)
IE (1) IE57967B1 (fr)
IL (1) IL73885A (fr)
IS (1) IS2968A7 (fr)
IT (1) IT1184304B (fr)
KE (1) KE3841A (fr)
LU (1) LU85721A1 (fr)
MA (1) MA20316A1 (fr)
MX (1) MX156277A (fr)
NL (1) NL8403979A (fr)
NO (1) NO160263C (fr)
NZ (1) NZ210606A (fr)
PH (1) PH22471A (fr)
PL (1) PL144349B1 (fr)
PT (1) PT79777B (fr)
RO (1) RO91262B (fr)
SE (1) SE461854B (fr)
SU (1) SU1410866A3 (fr)
YU (1) YU44485B (fr)
ZA (1) ZA8410143B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
CA2491572C (fr) * 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Compositions pharmaceutiques empechant la consommation abusive d'opioides et d'autres drogues
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP2007509971A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン メトホルミンの増加された吸収のための組成物及び投与形態物
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (fr) 2004-08-25 2006-03-09 The Uab Research Foundation Substances ameliorant l'absorption destinees a l'administration de medicaments
CA2743725A1 (fr) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilisation de compositions d'alkylglycoside et methodes a cet effet
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP2709645B1 (fr) 2011-05-18 2023-08-09 Eumederis Pharmaceuticals, Inc. Agents pharmaceutiques peptidiques améliorés
US10005817B2 (en) 2012-11-20 2018-06-26 Eumederis Pharmaceuticals, Inc. Peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
WO2014140699A1 (fr) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd Nouveau procédé de libération d'érythromycine et préparation de ses sels
CN117180445A (zh) 2014-05-28 2023-12-08 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
WO2019108729A1 (fr) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins : inhibiteurs cibles de biogenèse mitochondriale pour éradiquer les cellules souches cancéreuses
WO2019157099A1 (fr) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Formulations d'épinéphrine intranasale et méthodes de traitement d'une maladie
DE112019000683T5 (de) 2018-02-06 2020-10-15 Aegis Therapeutics, Llc Intranasale epinephrin-formulierungen und verfahren zur behandlung von erkrankungen
WO2020131696A1 (fr) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Trithérapies permettant de cibler les mitochondries et de tuer les cellules souches cancéreuses
CN113453690A (zh) * 2018-12-17 2021-09-28 卢内拉生物技术有限公司 用于抗衰老的三联疗法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK149776C (da) 1987-04-21
ATA985A (de) 1988-01-15
FR2557878A1 (fr) 1985-07-12
SE461854B (sv) 1990-04-02
IL73885A (en) 1988-10-31
KR900006237B1 (ko) 1990-08-27
ES539349A0 (es) 1986-04-01
FR2557878B1 (fr) 1988-01-15
IL73885A0 (en) 1985-03-31
AU565688B2 (en) 1987-09-24
HUT37628A (en) 1986-01-23
FI77249B (fi) 1988-10-31
HK11590A (en) 1990-02-23
MA20316A1 (fr) 1985-10-01
GB2152502B (en) 1987-10-07
ZA8410143B (en) 1985-08-28
IT8519012A0 (it) 1985-01-04
DE3500179A1 (de) 1985-07-18
JPH029040B2 (fr) 1990-02-28
NO850007L (no) 1985-07-08
NO160263B (no) 1988-12-19
YU2085A (en) 1987-12-31
PL251457A1 (en) 1985-11-05
SE8406671D0 (sv) 1984-12-28
CH666275A5 (de) 1988-07-15
PL144349B1 (en) 1988-05-31
PH22471A (en) 1988-09-12
RO91262B (ro) 1987-07-01
CA1224461A (fr) 1987-07-21
DE3500179C2 (fr) 1989-08-24
PT79777A (en) 1985-01-01
LU85721A1 (fr) 1985-07-24
FI77249C (fi) 1989-02-10
SE8406671L (sv) 1985-07-07
FI850023A0 (fi) 1985-01-03
CY1462A (en) 1989-07-21
JPS60158197A (ja) 1985-08-19
BG43189A3 (en) 1988-04-15
IE57967B1 (en) 1993-06-02
MX156277A (es) 1988-08-04
NL8403979A (nl) 1985-08-01
YU44485B (en) 1990-08-31
ES8605818A1 (es) 1986-04-01
GB8432368D0 (en) 1985-02-06
US4599326A (en) 1986-07-08
SU1410866A3 (ru) 1988-07-15
IT1184304B (it) 1987-10-28
KR850005452A (ko) 1985-08-26
IS2968A7 (is) 1985-04-03
HU196221B (en) 1988-10-28
AU3705984A (en) 1985-07-11
PT79777B (en) 1986-10-21
FI850023L (fi) 1985-07-07
NO160263C (no) 1989-03-29
IE850022L (en) 1985-07-06
CS247191B2 (en) 1986-12-18
NZ210606A (en) 1987-08-31
DK149776B (da) 1986-09-29
AT386414B (de) 1988-08-25
GB2152502A (en) 1985-08-07
KE3841A (en) 1989-04-07
DK5884D0 (da) 1984-01-06
RO91262A (fr) 1987-06-30
DK5884A (da) 1985-07-07

Similar Documents

Publication Publication Date Title
BE901411A (fr) Compose antiobiotique, procede pour le preparer et compositions le contenant.
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
FR2504535B1 (fr) Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
IL91159A0 (en) Tetrahydro-1-benz-(c,d)-indole-propionic acid sulphonamides,their preparation and pharmaceutical compositions containing them
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
KR840007579A (ko) 신규 니트로 알리파틱화합물의 제조방법
GB1448781A (en) N- omega-amino- alkylaniline compounds
GB1357929A (en) 2-phenyl-3-acylbenzothiazolines and their oxides
KR890008156A (ko) 깅콜리드의 신규 알콜시 유도체, 그 제조 방법 및 이를 함유한 치료 조성물
GB1513168A (en) Bisazomethine metal complex colourants of hydroxy-coumarin derivatives or hydroxy-chromone derivatives and process for their manufacture
BE904588A (fr) (-)-1Beta-ETHYL-1ALPHA-HYDROXYMETHYL-1,2,3,4,6,7,12,12beta alpha-OCTAHYDROINDOLO (2,3-a) QUINOLIZINE, PROCEDE POUR LA PREPARER ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CELLE-CI.
GB1388180A (en) Acetals
GB1360164A (en) 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of hydroxyalkyl hydroxyalkanoates
NO852748L (no) Monobasiske diisobutamid derivater.
IE34307B1 (en) New 1-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compound as an active ingredient
NO860114L (no) Imidazolderivater og fremgangsmaate til fremstilling derav.
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
GB1310779A (en) N-pyridylalkyl-beta-alkoxy-beta-trifluoromethylphenalkylamines
KR880001635A (ko) 5-플루오로우라실 유도체, 그의 제조방법 및 용도
GB8330731D0 (en) Chemical compounds
GB1425729A (en) 1,4-dihydropyridine compounds
GB1436982A (en) Imidazole derivatives and process for preparing them
KR920701185A (ko) 신규 티아졸리딘온 유도체, 그것을 함유하는 약학 조성물 및 그 제조방법
KR880012229A (ko) 3-아미노-4-에틸티오-퀴놀린 또는 그의 약학적으로 허용되는 산부가염의 제조방법, 그의 용도 및 이를 함유하는 약학적 조성물

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ORION-YHTYMA OY

Effective date: 19931231